GlassScriptPhysician profile
Edward U Kissel
NPI 1205834686
$2,245.37
in general payments reported to CMS, 2019-2025
24 companies · $977 in 2025
The $977 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2021: $185 · 2022: $221 · 2023: $274 · 2024: $231 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $535.05 | 2019-2025 | Axsos, Pangea, Mako |
| Sanara Medtech INC. | $258.13 | 2023-2024 | Celleraterx |
| Orthalign INC | $202.01 | 2025 | Orthalign Plus |
| Innovation Technologies INC | $168.43 | 2022 | |
| Osteoremedies, LLC | $166.12 | 2025 | Blastx, Xperience |
| Pacira Therapeutics, INC. | $154.86 | 2019-2021 | |
| Linvatec Corporation | $137.82 | 2025 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $102.93 | 2023-2025 | Orthovisc, Monovisc, Healix Knotless Peek |
| Janssen Pharmaceuticals, INC | $67.25 | 2021-2022 | |
| Smith+Nephew, INC. | $53.17 | 2019-2023 | Redapt, Real Intelligence |
| Heraeus Medical, LLC. | $50.93 | 2019 | |
| Conmed Corporation | $44.90 | 2023-2025 | Visiclear, Abc Handpieces, System 2450 |
| Ethicon US, LLC | $44.60 | 2021-2025 | Vistaseal, Ethicon, Surgiflo Hemostatic Matrix |
| Vertex Pharmaceuticals Incorporated | $37.97 | 2024-2025 | |
| Spr Therapeutics, INC | $31.20 | 2024 | Sprint Pns System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $28.61 | 2022 | |
| Convatec INC. | $26.81 | 2019 | |
| Baudax Bio INC. | $24.64 | 2021 | |
| Becton, Dickinson and Company | $23.20 | 2025 | Arista |
| Bioventus LLC | $23.15 | 2021 | |
| Heron Therapeutics, INC. | $18.18 | 2021 | |
| Abbott Laboratories | $16.61 | 2023 | Proclaim |
| Sanofi-Aventis U.S. LLC | $15.28 | 2019 | |
| Vericel Corporation | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Kissel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.